CA
NZ
UK
AU
IND
US
● Adjusted operating margin rose to 18.0 per cent, up 250 basis points.
● Adjusted operating margin fell to 19.6 per cent from 24.8 per cent a year earlier.
No company release dated October 16, 2026 explains the advance, and the print is thin. A volume of 200 shares at CAD 1.80 equals CAD 360 of value traded, with relative volume of 0.11, so a single small order can move a quote on …
Verastem (NASDAQ:VSTM) featured among the gainers in the Thursday, October 15, 2026 US regular session, closing at $9.23 for an advance of 19.71% on the day. The move came against a market that was otherwise defined by a sharp retreat in AI-linked and semiconductor …
Regencell Bioscience (NASDAQ:RGC) advanced sharply during the Thursday, October 15, 2026 US regular session, closing near $9.89 for a gain of roughly 22% on the day. The action is most reasonably understood through the lens of the stock’s well-documented trading characteristics: a limited public …
Recursion Pharmaceuticals (NASDAQ:RXRX), a biotechnology company that pairs machine learning and automated laboratory experimentation to search for new drug candidates, rose on Thursday, October 15, 2026, finishing at $4.16, a gain of 11.23% for the session. The advance is notable precisely because it ran …
PepGen (NASDAQ:PEPG), a clinical-stage biotechnology company working on oligonucleotide therapeutics, rose on Thursday, October 15, 2026, finishing at $2.53, a gain of 9.05% for the session. The move came on a day when the broad market was under pressure, with the major indexes dragged …
Picard Medical (NYSE American:PMI), a micro-cap maker of artificial heart technology, closed at $10.00 on Thursday, October 15, 2026, down $2.68, or 21.14%, from the prior close. The stock opened at $13.67 and spiked to an intraday high of $18.23 before reversing to close …
Prime Medicine (NASDAQ:PRME) was among the gainers in the US regular session on Thursday, October 15, 2026, climbing as investors rotated into healthcare and biotechnology shares and away from the artificial-intelligence and semiconductor names that dominated the day’s sell-off. The stock closed at $3.61, …
OPKO Health (NASDAQ:OPK) was among the gainers in the US regular session on Thursday, October 15, 2026, rising as investors rotated into healthcare shares and away from the artificial-intelligence and semiconductor names that led the day’s sell-off. The stock closed at $1.61, up 17.52% …
Please wait processing your request...